Professional move for German KBV:
This article was originally published in Clinica
Executive Summary
The German national association of health insurance physicians (KBV) has elected 44-year-old Andreas Koehler as its new principal chairman, with effect from February 1. Dr Kohler, who will serve a six-year term, was the choice of all but one of the 60 voters. He replaces Manfred Richter-Reichhelm. His appointment, and that of second chairman Ulrich Weigeldt, represents something of a new era for the KBV, as it is the first time that full-time professionals have been installed in the association's senior executive posts. Medtech industry association BVMed has good contacts with Dr Kohler, and says it will continue to work closely with the doctors' association.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.